This topic contains a solution. Click here to go to the answer

Author Question: Which of the Big Five traits continues to increase after the age of 50? a. agreeableness b. ... (Read 17 times)

809779

  • Hero Member
  • *****
  • Posts: 579
Which of the Big Five traits continues to increase after the age of 50?
 
  a. agreeableness
  b. neuroticism
  c. openness
  d. extraversion

Question 2

As people age from young adulthood to old age, they tend to become __________.
 
  a. more neurotic and more conscientious
  b. less neurotic and more conscientious
  c. less neurotic and less conscientious
  d. more neurotic and less conscientious



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ddddd

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Answer: A

Answer to Question 2

Answer: B




809779

  • Member
  • Posts: 579
Reply 2 on: Jun 21, 2018
Great answer, keep it coming :)


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Excellent

 

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library